JPRN-UMIN000021589招募中未知
The effect of anti-VEGF treatments for neovascular,exudative and inflammatory ocular diseases - The ocular effect of anti-VEGF treatments
The department of ophthalmology,Tohoku university graduate School of Medicine0 个研究点目标入组 3,000 人开始时间: 2016年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Children, and adults who can not understand this study or do not have a consciousness.
研究者
相似试验
尚未招募
不适用
Evaluation of the responsiveness of anti-VEGF treatment in DMEdiabetic retinopathy (DR)NL-OMON29053GSMS70
已完成
不适用
Clinical study in new protocol of anti-VEGF agents for macular edema with retinal vein occlusion and in relation between the protocol and cytokinesRetinal Vein OcclusionJPRN-UMIN000030311Tokyo medical university100
已完成
不适用
Anti-VEGF monotherapy versus combined anti-VEGF and end-point-management grid laser photocoagulation for diabetic macular edemaDiabetic macular edemaJPRN-UMIN000017818niversity of Hong Kong, Nagoya City University Graduate school of Medical Sciences200
暂停
不适用
The effect of an anti-VEGF drug on proliferative diabetic retinopathy complicated with diabetic macular edemaproliferative diabetic retinopathy complicated with diabetic macular edemaJPRN-UMIN000027618Tokyo Women's Medical University30
进行中（未招募）
1 期
To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaTreatment Naïve Neovascular Age-Related Macular Degeneration (nAMD) and Treatment Naïve diabetic macular edema (DME)MedDRA version: 20.0Level: SOCClassification code 10015919Term: Eye disordersSystem Organ Class: 10015919 - Eye disordersEUCTR2020-003515-10-PLF. Hoffmann-La Roche Ltd200